| manager |
|
| language |
- |
| license |
- |
| created at |
2017-12-21 11:07:16 UTC |
| updated at |
2017-12-21 12:22:32 UTC |
|
2 layers
|
143,100 entries
|
There is 0 pattern entry.
|
UNAPPROVED DRUG OTHER MARKETING CATEGORY
|
CONC:NCI_FDA |
|
|
BLISTER
|
CONC:NCI_FDA |
|
|
Blister
|
CONC:NCI_FDA |
|
|
CELL CULTURE INFECTIOUS DOSE 50%
|
CONC:NCI_FDA |
|
|
MANUFACTURER
|
CONC:NCI_FDA |
|
|
Generic Drug Enforcement Act Statement
|
CONC:NCI_FDA |
|
|
General Investigational Plan
|
CONC:NCI_FDA |
|
|
Genotoxicity: In Vitro
|
CONC:NCI_FDA |
|
|
Genotoxicity: In Vivo
|
CONC:NCI_FDA |
|
|
Healthy Subject PK And Initial Tolerability Study Reports And Related Information
|
CONC:NCI_FDA |
|
|
Healthy Subject PD And PK/PD Study Reports And Related Information
|
CONC:NCI_FDA |
|
|
In Vitro - In Vivo Correlation Study Reports And Related Information
|
CONC:NCI_FDA |
|
|
Inactivation Request
|
CONC:NCI_FDA |
|
|
Individual Study Information
|
CONC:NCI_FDA |
|
|
Information Amendment: Information Not Covered Under Modules 2 To 5
|
CONC:NCI_FDA |
|
